Suven Life Sciences announces promising results at 76th American Academy of Neurology Meeting
Suven Life Sciences, a clinical-stage biopharmaceutical company focused on the development of novel treatments for Central Nervous System (CNS) disorders, is set to present significant study results at the 76th American Academy of Neurology (AAN) Annual Meeting. The event will take place from April 13 to 18, 2024, in Denver, USA, as well as virtually. […]